(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BLACK DIAMOND THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BLACK DIAMOND THERAPEUTICS

ST13

US500000088564765

Class

42

Filing

88564765

Registration

6198088

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

11/18/2025

Trademark type

Combined

Nice classes

42

Filing date

08/02/2019

Registration date

11/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/17/2020

Last transaction

11/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/02/2018

First use in commerce

01/02/2018

Drawing code

3

Owner type

03

Owner location

Cambridge, MA

Examiner

BAYLISS,HUNTER A

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a diamond-shaped design which is split in its upper portion. To the right of the design, and separately one above each other, are the terms "BLACK, DIAMOND" and "THERAPEUTICS", all in upper case capital letters.

Holders and representatives

Holders

Black Diamond Therapeutics, Inc.

Representatives

Jessica L. Rothstein GOODWIN PROCTER LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical research services in connection with identifying genes and biomarkers relevant for cancer; Pharmaceutical research and development services; research and development services in the field of diagnostic tools and tests for identifying patients with genetic mutations or biomarkers relevant to oncology treatment

Publications

History of USPTO decisions and trademark events.

40 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/17/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/19/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/19/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/19/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/19/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/19/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/17/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/01/2020

PUBO

PUBLISHED FOR OPPOSITION

09/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/12/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/30/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

07/29/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/29/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

07/29/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/29/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/19/2020

GNFR

FINAL REFUSAL E-MAILED

06/19/2020

CNFR

FINAL REFUSAL WRITTEN

06/19/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/27/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/27/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/27/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/06/2020

ALIE

ASSIGNED TO LIE

05/05/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/01/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/01/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/01/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/01/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/01/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/01/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/27/2019

GNRT

NON-FINAL ACTION E-MAILED

11/27/2019

CNRT

NON-FINAL ACTION WRITTEN

11/27/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

11/08/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/08/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

11/08/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/08/2019

DOCK

ASSIGNED TO EXAMINER

10/31/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/23/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/22/2019

NWAP

NEW APPLICATION ENTERED

08/06/2019

Continuous trademark protection

Get notified about every new filing that threatens BLACK DIAMOND THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.